Serum LRG1 as a novel biomarker for cardioembolic stroke

Meng Zhang1, Yuan Wang1, Jing Wang1

  • 1Department of Neurology, The Affiliated Hospital of Qingdao University, Qingdao 266000, China.

Insights

Leucine-rich alpha-2 glycoprotein 1 (LRG1) shows potential in identifying cardioembolic stroke. Higher LRG1 levels indicate increased stroke severity and poorer prognosis.

Area of Science:

  • Cardiology
  • Neurology
  • Biomarker Discovery

Background:

  • Leucine-rich alpha-2 glycoprotein 1 (LRG1) is linked to cardiovascular conditions like atrial fibrillation and heart failure.
  • The role of LRG1 in cerebral infarction remains debated.
  • LRG1's potential in identifying cardioembolic stroke requires further investigation.

Purpose of the Study:

  • To evaluate the diagnostic value of serum LRG1 levels for detecting cardioembolic (CE) stroke.
  • To assess LRG1's correlation with stroke severity and short-term prognosis.

Main Methods:

  • Serum LRG1 levels were measured using ELISA in 283 acute ischemic stroke (AIS) patients and 169 controls.
  • AIS patients were categorized into CE and non-CE groups.
  • LRG1's predictive performance was compared with established markers like BNP and LAD.

Main Results:

  • Serum LRG1 levels were lower in AIS patients overall but higher in the CE group compared to the non-CE group.
  • LRG1 demonstrated independent predictive value for CE stroke with an AUC of 0.768.
  • A combined model of LRG1, BNP, and LAD significantly enhanced predictive accuracy.
  • Elevated LRG1 correlated with greater stroke severity and poorer 3-month outcomes in CE patients.

Conclusions:

  • Serum LRG1 is a promising biomarker for predicting cardioembolic stroke.
  • LRG1 may also serve as an indicator for stroke severity and prognosis.
  • Further research can explore LRG1's clinical utility in stroke management.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
313
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
503
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
407
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
74
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
197